These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 26423305)

  • 1. Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer.
    Puhan MA; Yu T; Stegeman I; Varadhan R; Singh S; Boyd CM
    BMC Med; 2015 Oct; 13():250. PubMed ID: 26423305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis.
    Stegeman I; Bossuyt PM; Yu T; Boyd C; Puhan MA
    PLoS One; 2015; 10(7):e0127194. PubMed ID: 26151751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.
    Dehmer SP; Maciosek MV; Flottemesch TJ; LaFrance AB; Whitlock EP
    Ann Intern Med; 2016 Jun; 164(12):777-86. PubMed ID: 27064573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention: A Benefit-Harm Analysis.
    Selak V; Jackson R; Poppe K; Wu B; Harwood M; Grey C; Pylypchuk R; Mehta S; Choi YH; Kerr A; Wells S
    Ann Intern Med; 2019 Oct; 171(8):529-539. PubMed ID: 31525775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease: Advances in Diagnosis and Treatment.
    Mora S; Manson JE
    JAMA Intern Med; 2016 Aug; 176(8):1195-204. PubMed ID: 27322595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Aspirin in the Primary Prevention of Cardiovascular Diseases and Cancer in the Elderly: A Population-Based Cohort Study in Korea.
    Jung M; Lee S
    Drugs Aging; 2020 Jan; 37(1):43-55. PubMed ID: 31755069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin for primary prevention: yes or no?
    Selak V; Elley CR; Wells S; Rodgers A; Sharpe N
    J Prim Health Care; 2010 Jun; 2(2):92-9. PubMed ID: 20690297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of aspirin treatment strategies for primary prevention of cardiovascular diseases: A decision-analytic Markov modelling study].
    Zhang ML; Liu QP; Gong C; Wang JM; Zhou TJ; Liu XF; Shen P; Lin HB; Tang X; Gao P
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):480-487. PubMed ID: 37291924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study.
    Yebyo HG; Aschmann HE; Puhan MA
    Ann Intern Med; 2019 Jan; 170(1):1-10. PubMed ID: 30508425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease?
    Selak V; Jackson R; Poppe K; Kerr A; Wells S
    N Z Med J; 2018 Oct; 131(1484):19-25. PubMed ID: 30359352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose aspirin and upper gastrointestinal bleeding in primary versus secondary cardiovascular prevention: a population-based, nested case-control study.
    Lin KJ; De Caterina R; García Rodríguez LA
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):70-7. PubMed ID: 24254886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study.
    Yebyo HG; Zappacosta S; Aschmann HE; Haile SR; Puhan MA
    BMC Cardiovasc Disord; 2020 Sep; 20(1):418. PubMed ID: 32942999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
    ; Baigent C; Blackwell L; Collins R; Emberson J; Godwin J; Peto R; Buring J; Hennekens C; Kearney P; Meade T; Patrono C; Roncaglioni MC; Zanchetti A
    Lancet; 2009 May; 373(9678):1849-60. PubMed ID: 19482214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.
    US Preventive Services Task Force
    Ann Intern Med; 2009 Mar; 150(6):396-404. PubMed ID: 19293072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds.
    Kolber MR; Korownyk C
    Expert Opin Pharmacother; 2014 Feb; 15(2):153-7. PubMed ID: 24206142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.
    Bibbins-Domingo K;
    Ann Intern Med; 2016 Jun; 164(12):836-45. PubMed ID: 27064677
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.